Page 4 - Nasdaq Scph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wall Street analysts expect scPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) to announce earnings of ($0.33) per share for the current quarter, according to Zacks. Zero analysts have issued estimates for scPharmaceuticals’ earnings. The lowest EPS estimate is ($0.36) and the highest is ($0.29). scPharmaceuticals posted earnings per share of ($0.26) during the same quarter last […]

ScPharmaceuticals (NASDAQ:SCPH – Get Rating) released its quarterly earnings results on Monday. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08, MarketWatch Earnings reports. NASDAQ:SCPH opened at $4.69 on Tuesday. The stock’s fifty day moving average price is $5.22 and its two-hundred day moving average price is $5.01. […]

ScPharmaceuticals (NASDAQ:SCPH – Get Rating) had its price target boosted by investment analysts at SVB Leerink to $6.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The firm presently has a “market perform” rating on the stock. SVB Leerink’s target price points to a potential upside of 26.58% from the […]

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors February 17, 2021 08:00 ET | Source: scPharmaceuticals, Inc. scPharmaceuticals, Inc. Burlington, Massachusetts, UNITED STATES BURLINGTON, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the...